- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03965403
Upper Extremity Rehabilitation With the BURT Robotic Arm
Upper Extremity Rehabilitation With the BURT Robotic Arm: a Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02129
- Spaulding Rehabilitation Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male and female, age 18-80;
- Having had a stroke (ischemic or hemorrhagic) at least 6 months prior to study
- Moderate to severe upper-limb motor impairments (score of 15-45 out of 66 on the Fugl- Meyer Scale);
- Community dwelling;
- Able to physically fit in the device.
Exclusion Criteria:
- Current participation in rehabilitation program targeting upper extremity function;
- Cognitive impairment resulting to inability to follow instructions or inability to sustain attention for more than 10 minutes;
- Visual impairments not corrected with lenses (visual loss);
- Aphasia sufficient to limit comprehension and completion of the treatment protocol;
- No more than moderate impairments in paretic UE sensation, passive range of motion, and pain that would limit ability to engage in therapy;
- Increased muscle tone (passive movement is difficult);
- Previous diagnosis of neurological diseases other than stroke;
- Other conditions affecting function of the stroke affected upper limb;
- Individuals who present with the following: open wounds, fragile skin, active infection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm motor function retraining with BURT
All participants will receive 1 hour sessions, 2-3x/week for 6 weeks (total 18 sessions).
Sessions will be organized with 30 minutes of robotic-assisted training and 30 minutes of hands-on training with a research therapist to work on the baseline goals of the subject.
Hands-on training will be done with routinely employed techniques in therapy to transfer the skills gained with the robotic device in everyday life activities.
|
Intervention will be focused on patients impairments to assess the feasibility of the BURT device to carry-on long interventions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes From Baseline in Fugl-Meyer Upper Extremity Scores
Time Frame: 6 weeks
|
Assessment of upper extremity impairments.
Individual items of the scale are summed for a total score ranking from 0 to 66. Higher scores indicate better outcomes.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes From Baseline in Goal Attainment Scale Scores
Time Frame: 6 weeks
|
Standardized measure of goals selection and scaling to calculate the extend to which the participant's goals are met. The Goal Attainment Scale ranges from -2 to +2. Positive scores indicates goals are better than expected, score of 0 indicates goals are met and negative scores indicates goals aren't met. |
6 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes From Baseline in Wolf Motor Function Test Scores (Time Subscale)
Time Frame: 6 weeks
|
Assessment of upper-extremity function by the performance time of the Wolf Motor Function Test).
The average of the 15 items is reported.
The time ranges from 0 to 120 seconds.
A decrease in performance time is associated with improved upper-extremity function.
|
6 weeks
|
|
Changes From Baseline in Motor Activity Log Scores
Time Frame: 6 weeks
|
Use of upper extremity in daily life.
The self-reported amount of use is reported on a scale from 0 to 5. A score of zero is assigned when the hemiparetic side is not used during the activity of daily living, a score of 5 is assigned when the hemiparetic side is used as much as before the stroke.
The 30 items of the scale are averaged.
Higher scores are a sign of better use in daily life.
|
6 weeks
|
|
Changes From Baseline in Modified Ashworth Scale Scores
Time Frame: 6 weeks
|
Assessment of muscle tone for upper extremity muscles. Score rank from 0 (no tone) to 4 (no movement possible). Lower scores indicates a better outcome. Tone at the shoulder and elbow were measured |
6 weeks
|
|
Changes From Baseline in Articulations Range of Motion
Time Frame: 6 weeks
|
Assessment of active arm range of motion with goniometry.
Results are reported in degrees and higher ranges include better outcomes.
|
6 weeks
|
|
Changes From Baseline in Manual Muscle Testing Scale Scores
Time Frame: 6 weeks
|
Assessment of arm muscle strength using the manual muscle testing scale ranking from 0 (no contraction) to 10 (maximal strength).
Higher scores indicate better outcomes.
|
6 weeks
|
|
Changes From Baseline in Wolf Motor Function Test Scores (FAS Subcale)
Time Frame: 6 weeks
|
Assessment of upper-extremity function with the Functional ability subscale of the Wolf Motor Function Test. The average of the 15 items is reported. Scores ranges from 0 to 5, they rate the quality of the movement performance. 0= do not attempt, up to 5= identical to contralateral side. Higher scores are associated with better movement quality. |
6 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016P002590
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Arm motor function retraining with BURT
-
Massachusetts General HospitalDana Foundation, Spaulding Rehabilitation HospitalTerminatedStroke | Upper Extremity ParesisUnited States
-
Abant Izzet Baysal UniversityRecruitingDiplegic Cerebral PalsyTurkey
-
Hacettepe UniversityCompleted
-
University of Nove de JulhoCompletedPeripheral Arterial DiseaseBrazil
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenNot yet recruitingChemotherapy-Induced Peripheral Neuropathy | CIPN - Chemotherapy-Induced Peripheral Neuropathy | Chemotherapy-Induced Peripheral Neuropathy in Breast CancerBelgium
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Cognitive/Functional EffectsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingQuality of Life | Hodgkin Lymphoma | Non Hodgkin Lymphoma | Stage I Breast Cancer | Stage II Breast Cancer | Stage III Breast Cancer | Heart; Functional DisturbanceUnited States
-
Erasme University HospitalUniversité Libre de Bruxelles; King Baudouin Foundation; Fonds Erasme pour la...Active, not recruitingBreastfeeding | Breastfeeding Outcomes | Ankyloglossia | Breastfeeding Duration | Breastfeeding Self-EfficacyBelgium
-
Azienda Sanitaria di FirenzeNot yet recruitingDiverticular Disease of Colon
-
Marmara UniversityUnknown